يعرض 1 - 10 نتائج من 68 نتيجة بحث عن '"septin 9"', وقت الاستعلام: 1.98s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية

    المصدر: Pathogens; Volume 10; Issue 10; Pages: 1327

    مصطلحات موضوعية: HCV, PIAS1, septin 9, lipid droplets

    جغرافية الموضوع: agris

    وصف الملف: application/pdf

    العلاقة: Viral Pathogens; https://dx.doi.org/10.3390/pathogens10101327Test

  7. 7
  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية

    المساهمون: The study was performed as a part of an experimental state task from the Ministry of Health of the Russian Federation under supervision of the Center for Strategic Planning and Management of Medical and Biological Health Risks, Ministry of Health of the Russian Federation, Данное исследование выполняется в рамках экспериментального государственного задания Министерства здравоохранения Российской Федерации при координации ФГБУ «Центр стратегического планирования и управления медико-биологическими рисками здоровью» Минздрава России

    المصدر: Advances in Molecular Oncology; Том 6, № 4 (2019); 26-37 ; Успехи молекулярной онкологии; Том 6, № 4 (2019); 26-37 ; 2413-3787 ; 2313-805X ; 10.17650/2313-805X-2019-6-4

    وصف الملف: application/pdf

    العلاقة: https://umo.abvpress.ru/jour/article/view/239/190Test; Bray F., Ferlay J., Soerjomataram I. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortal ity worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018. DOI:10.3322/caac.21492.; Llovet J.M., Zucman-Rossi J., Pikarsky E. et al. Hepatocellular carcinoma. Nat Rev Dis Primers 2016;2:16018. DOI:10.1038/nrdp.2016.18.; Kulik L., El-Serag H.B. Epidemiology and management of hepatocellular carcinoma. Gastroenterology 2019;156(2):477–91.e1. DOI:10.1053/j.gastro.2018.08.065.; Abelev G.I., Eraiser T.L. Cellular aspects of alpha-fetoprotein reexpression in tumors. Semin Cancer Biol 1999;9(2):95–107.; Rich N., Singal A.G. Hepatocellular carcinoma tumour markers: current role and expectations. Best Pract Res Clin Gastroenterol 2014;28(5):843–53. DOI:10.1016/j.bpg.2014.07.018.; Gai W., Sun K. Epigenetic Biomarkers in Cell-Free DNA and Applications in Liq uid Biopsy. Genes (Basel) 2019;10(1). DOI:10.3390/genes10010032.; Кустова И.Ф., Макарова А.С., Лазаревич Н.Л. Потенциал использования биомаркеров метилирования для диагностики и прогноза гепатоцеллюлярной карциномы методом жидкостной биопсии. Успехи молекулярной онкологии 2018;5(4):8–19. DOI:10.17650/2313-805X-2018.; De Vos T., Tetzner R., Model F. et al. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem 2009;55(7):1337–46. DOI:10.1373/clinchem.2008.115808.; Wasserkort R., Kalmar A., Valcz G. et al. Aberrant septin 9 DNA methylation in colorectal cancer is restricted to a single CpG island. BMC Cancer 2013;13:398. DOI:10.1186/1471-2407-13-398.; Epigenomics, 2016. Epi proColon®. Available at: https://www.accessdata.fda.gov/cdrh_docs/pdf13/P130001C.pdfTest. Accessed date: 1 October 2019.; Shen N., Wang T., Li D. et al. Hyper methylation of the Sept9 gene suggests significantly poor prognosis in cancer patients: a systematic review and metaanalysis. Front Genet 2019;10:887. DOI:10.3389/fgene.2019.00887.; Villanueva A., Portela A., Sayols S. et al. DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma. Hepatology 2015;61(6):1945–56. DOI:10.1002/hep.27732.; Oussalah A., Rischer S., Bensenane M. et al. Plasma mSEPT9: a novel circulating cell-free DNA-based epigenetic biomarker to diagnose hepatocellular carcinoma. EBioMedicine 2018;30:138–47. DOI:10.1016/j.ebiom.2018.03.029.; Li J., Zhou X., Liu X. Detection of colorectal cancer in circulating cell-free DNA by methylated CpG tandem amplification and sequencing. Clin Chem 2019;65(7):916–26. DOI:10.1373/clinchem.2019.301804.; Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell 2017;169(7):1327–41.e23. DOI:10.1016/j.cell.2017.05.046.; Li L.C., Dahiya R. MethPrimer: designing primers for methylation PCRs. Bio informatics 2002;18(11):1427–31. DOI:10.1093/bioinformatics/18.11.1427.; Illumina, 2011. Available at: https://support.illumina.com/array/array_kits/infinium_humanmethylation450_beadchip_kit/downloads.htmlTest. Accessed date: 1 October 2019.; Xiong Y., Wei Y., Gu Y. et al. DiseaseMeth version 2.0: a major expansion and update of the human disease methylation database. Nucleic Acids Res 2017;45(D1):D888–95. DOI:10.1093/nar/gkw1123.; Li R., Liang F., Li M. et al. MethBank 3.0: a database of DNA methylomes across a variety of species. Nucleic Acids Res 2018;46(D1):D288–95. DOI:10.1093/nar/gkx1139.; Состояние онкологической помощи населению России в 2017 году. Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2018. 236 с.; Wittwer C.T., Herrmann M.G., Moss A.A., Rasmussen R.P. Continuous fluorescence monitoring of rapid cycle DNA amplification. Biotechniques 1997;22(1):130–1. DOI:10.2144/97221bi01.; Malentacchi F., Forni G., Vinci S., Orlando C. Quantitative evaluation of DNA methylation by optimization of a differentialhigh resolution melt analysis protocol. Nucleic Acids Res 2009;37(12):e86. DOI:10.1093/nar/gkp383.; Bergheim J., Semaan A., Gevensleben H. et al. Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study. Br J Cancer 2018;118(9):1217–28. DOI:10.1038/s41416-018-0035-8.; Song L., Yu H., Jia J., Li Y. A systematic review of the performance of the SEPT9 gene methylation assay in colorectal cancer screening, monitoring, diagnosis and prognosis. Cancer Biomark 2017;18(4):425–32. DOI:10.3233/CBM-160321.; https://umo.abvpress.ru/jour/article/view/239Test

  10. 10